PT91869A - Processo para a preparacao de um novo derivado da 1,4-dihidro-piridina denominado (-)2-<{2-(2-amino-etoxi)-etoxi}-metil>-4-(2,3-dicloro-fenil)-3-etoxicarbomil--5-metoxicarbonil-6-metil-1,4-dihidro-piridina - Google Patents

Processo para a preparacao de um novo derivado da 1,4-dihidro-piridina denominado (-)2-<{2-(2-amino-etoxi)-etoxi}-metil>-4-(2,3-dicloro-fenil)-3-etoxicarbomil--5-metoxicarbonil-6-metil-1,4-dihidro-piridina

Info

Publication number
PT91869A
PT91869A PT91869A PT9186989A PT91869A PT 91869 A PT91869 A PT 91869A PT 91869 A PT91869 A PT 91869A PT 9186989 A PT9186989 A PT 9186989A PT 91869 A PT91869 A PT 91869A
Authority
PT
Portugal
Prior art keywords
methyl
etoxy
dihydro
pyridine
methoxycarbonyl
Prior art date
Application number
PT91869A
Other languages
English (en)
Other versions
PT91869B (pt
Inventor
Jean-Louis Peglion
Yves-Michael Gargouil
Jean-Paul Vilaine
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of PT91869A publication Critical patent/PT91869A/pt
Publication of PT91869B publication Critical patent/PT91869B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT91869A 1989-07-04 1989-10-02 Processo para a preparacao de um novo derivado da 1,4-dihidro-piridina denominado (-)2-<{2-(2-amino-etoxi)-etoxi}-metil>-4-(2,3-dicloro-fenil)-3-etoxicarbomil--5-metoxicarbonil-6-metil-1,4-dihidro-piridina PT91869B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8908920A FR2649395B1 (fr) 1989-07-04 1989-07-04 Nouveau derive de la dihydro-1,4 pyridine denomme (-) Ÿi1Ÿ(((amino-2 ethoxy)-2 ethoxy) methylŸi1Ÿ) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent

Publications (2)

Publication Number Publication Date
PT91869A true PT91869A (pt) 1991-03-20
PT91869B PT91869B (pt) 1995-07-18

Family

ID=9383413

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91869A PT91869B (pt) 1989-07-04 1989-10-02 Processo para a preparacao de um novo derivado da 1,4-dihidro-piridina denominado (-)2-<{2-(2-amino-etoxi)-etoxi}-metil>-4-(2,3-dicloro-fenil)-3-etoxicarbomil--5-metoxicarbonil-6-metil-1,4-dihidro-piridina

Country Status (14)

Country Link
EP (1) EP0406502B1 (pt)
JP (1) JPH0720934B2 (pt)
AT (1) ATE122340T1 (pt)
AU (1) AU619049B2 (pt)
CA (1) CA1327582C (pt)
DE (1) DE68922605T2 (pt)
DK (1) DK478989A (pt)
ES (1) ES2074472T3 (pt)
FR (1) FR2649395B1 (pt)
IE (1) IE67059B1 (pt)
NZ (1) NZ230854A (pt)
OA (1) OA09136A (pt)
PT (1) PT91869B (pt)
ZA (1) ZA897349B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652083B1 (fr) * 1989-09-20 1992-01-24 Ador Cie Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
FR2686879B1 (fr) * 1992-02-05 1994-03-18 Adir Cie Nouveaux composes de 1,4-dihydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE4444864A1 (de) * 1994-12-16 1996-06-20 Bayer Ag Verwendung von 5-Acyl-1,4-dihydropyridinen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
IE67059B1 (en) 1996-02-21
IE893103A1 (en) 1991-01-16
CA1327582C (fr) 1994-03-08
FR2649395A1 (fr) 1991-01-11
PT91869B (pt) 1995-07-18
JPH0344371A (ja) 1991-02-26
NZ230854A (en) 1991-02-26
DK478989A (da) 1991-01-05
OA09136A (fr) 1991-10-31
DE68922605T2 (de) 1996-01-04
FR2649395B1 (fr) 1992-11-06
ATE122340T1 (de) 1995-05-15
EP0406502B1 (fr) 1995-05-10
DE68922605D1 (de) 1995-06-14
DK478989D0 (da) 1989-09-28
AU4239089A (en) 1991-01-10
ZA897349B (en) 1990-09-26
JPH0720934B2 (ja) 1995-03-08
EP0406502A1 (fr) 1991-01-09
ES2074472T3 (es) 1995-09-16
AU619049B2 (en) 1992-01-16

Similar Documents

Publication Publication Date Title
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
NO891698L (no) Pyridonkarboksylsyrederivater og fremgangsmaate for deres fremstilling.
DE69628276D1 (de) Zubereitung von xanthinderivaten als feste dispersion
NO913136D0 (no) Preparat for oeyedraaper.
DE69418243D1 (de) N-Heteroaryl-N&#39;-Phenylharnstoffderivate, ihre Herstellung und Verwendung
PT102145A (pt) Derivados de piperazina acetamida, processo para a sua preparacao e composicoes farmaceuticas.
PT99251A (pt) Processo para a preparacao de derivados de piperazina
PT91869A (pt) Processo para a preparacao de um novo derivado da 1,4-dihidro-piridina denominado (-)2-&lt;{2-(2-amino-etoxi)-etoxi}-metil&gt;-4-(2,3-dicloro-fenil)-3-etoxicarbomil--5-metoxicarbonil-6-metil-1,4-dihidro-piridina
MX9200777A (es) 4-[(2-benzotiazolil)metilamino]-alfa-[(3,4-difluorofenoxi)metil]-1-pip eridetanol.
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
EP0317259A3 (en) Heterocyclic insecticides
NO985202L (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
AU9462298A (en) Process for producing 3-cephem compounds
DE69830850D1 (de) Aminderivate und verfahren zu ihrer herstellung
ATE163010T1 (de) 4-(3-(4-oxothiazoldinyl)&gt;butynylamine, verfahren zu deren herstellung und ihre verwendung als medikament
DK74594A (da) Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980930